SPRY
NASDAQ · Biotechnology
Ars Pharmaceuticals Inc
$8.56
+0.30 (+3.63%)
Open$8.25
Previous Close$8.26
Day High$8.64
Day Low$8.12
52W High$18.90
52W Low$6.66
Volume—
Avg Volume1.75M
Market Cap893.68M
P/E Ratio—
EPS$-1.74
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+670.0% upside
Current
$8.56
$8.56
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 89.26M | 357.40M | 350.63M |
| Net Income | -181,439,135 | 35.24M | 44.72M |
| Profit Margin | -203.3% | 9.9% | 12.8% |
| EBITDA | -177,920,809 | 65.64M | 71.27M |
| Free Cash Flow | — | 46.75M | 30.69M |
| Rev Growth | +299.7% | +16.3% | -1.3% |
| Debt/Equity | 0.84 | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |